Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemal Mehta

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Ophthalmology. Retina|December 12, 2022
ReplyJanika Shah, Vuong Nguyen, Adrian Hunt, et al.
Retina (Philadelphia, Pa.)|February 17, 2022
THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: Data from the Fight Retinal Blindness! RegistryPierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, et al.
Ophthalmology. Retina|April 25, 2019
Development of New Proliferative Diabetic Retinopathy in the BEVORDEX TrialHemal Mehta, Lyndell L Lim, Vuong Nguyen, et al.
Ophthalmology. Retina|March 21, 2022
Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! ProjectJanika Shah, Vuong Nguyen, Adrian Hunt, et al.
The British Journal of Ophthalmology|November 4, 2016
Natural history and effect of therapeutic interventions on subretinal fluid causing foveal detachment in macular telangiectasia type 2Hemal Mehta, Simone Müller, Catherine A Egan, et al.
Clinical & Experimental Ophthalmology|November 20, 2025
Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! RegistryTrung M Dang, Alessandro Invernizzi, Vuong Nguyen, et al.
Clinical & Experimental Ophthalmology|December 28, 2024
Outliers of Treatment Frequency in Retinal Vein Occlusion: 24-Month Comparative Analysis of Fight Retinal Blindness! PractitionersTheodorus Ponsioen, Yohei Hashimoto, Alessandro Invernizzi, et al.
The British Journal of Ophthalmology|January 26, 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, et al.
Ophthalmology. Retina|April 19, 2024
Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion: Fight Retinal Blindness!Socorro Alforja, Adrian Hunt, Vuong Nguyen, et al.
Ophthalmology. Retina|November 12, 2022
Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF: The Fight Retinal Blindness! RegistryAdrian Hunt, Vuong Nguyen, Sanjeeb Bhandari, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Ophthalmology. Retina|December 12, 2022
ReplyJanika Shah, Vuong Nguyen, Adrian Hunt, et al.
Retina (Philadelphia, Pa.)|February 17, 2022
THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: Data from the Fight Retinal Blindness! RegistryPierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, et al.
Ophthalmology. Retina|April 25, 2019
Development of New Proliferative Diabetic Retinopathy in the BEVORDEX TrialHemal Mehta, Lyndell L Lim, Vuong Nguyen, et al.
Ophthalmology. Retina|March 21, 2022
Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! ProjectJanika Shah, Vuong Nguyen, Adrian Hunt, et al.
The British Journal of Ophthalmology|November 4, 2016
Natural history and effect of therapeutic interventions on subretinal fluid causing foveal detachment in macular telangiectasia type 2Hemal Mehta, Simone Müller, Catherine A Egan, et al.
Clinical & Experimental Ophthalmology|November 20, 2025
Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! RegistryTrung M Dang, Alessandro Invernizzi, Vuong Nguyen, et al.
Clinical & Experimental Ophthalmology|December 28, 2024
Outliers of Treatment Frequency in Retinal Vein Occlusion: 24-Month Comparative Analysis of Fight Retinal Blindness! PractitionersTheodorus Ponsioen, Yohei Hashimoto, Alessandro Invernizzi, et al.
The British Journal of Ophthalmology|January 26, 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, et al.
Ophthalmology. Retina|April 19, 2024
Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion: Fight Retinal Blindness!Socorro Alforja, Adrian Hunt, Vuong Nguyen, et al.
Ophthalmology. Retina|November 12, 2022
Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF: The Fight Retinal Blindness! RegistryAdrian Hunt, Vuong Nguyen, Sanjeeb Bhandari, et al.
Pageof 9